Oppenheimer analyst Rupesh Parikh raised the firm’s price target on Estee Lauder to $300 from $245 and keeps an Outperform rating on the shares. For the quarter, the analyst expects "one last softish delivery" driven by continued COVID-19 headwinds weighing disproportionately on the company’s mainland China business. However, with easing COVID-19 restrictions in China and loosening of travel restrictions, along with a weakening U.S. dollar, Parikh now believes Estee Lauder is positioned for a powerful sales and EPS recovery. Estee Lauder remains a top-pick for the analyst, who believes the missing ingredients are finally coming into place to drive sustained sales and profit growth.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on EL:
- Estee Lauder price target raised to $285 from $274 at JPMorgan
- Estee Lauder price target raised to $290 from $255 at Piper Sandler
- Early notable gainers among liquid option names on December 21st
- Bernstein personal products analyst holds analyst/industry conference call
- Buy/Sell: Wall Street’s top 10 stock calls this week